Aktuelle Fragen des med.-wiss. Publikationswesens (Teil 3)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie[Bearbeiten]

  1. Medical journal editing: who shall pay? Ann Intern Med 151(1):68-9 (2009) PMID 19581649
  2. ACP Journal Club. What kind of randomized trials do patients and clinicians need? Ann Intern Med 150(10):JC5-2, JC5-3 (2009) PMID 19451559
  3. ACP Journal Club. Interpreting meta-analyses in systematic reviews. Ann Intern Med 150(4):JC2-2, JC2-3 (2009) PMID 19238601
  4. The science and art of deduction: complex systematic overviews. Ann Intern Med 148(10):786-8 (2008) PMID 18490692
  5. Using existing systematic reviews in complex systematic reviews. Ann Intern Med 148(10):776-82 (2008) PMID 18490690
  6. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 147(4):224-33 (2007) PMID 17638714
  7. Clinical trial registration: looking back and moving ahead. Ann Intern Med 147(4):275-7 (2007) PMID 17548404
  8. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 146(12):878-81 (2007) PMID 17577007
  9. Institutional review board review of multicenter studies. Ann Intern Med 146(10):759 (2007) PMID 17502642
  10. Career changes in medicine: Part II. Ann Intern Med 145(10):782-3 (2006) PMID 17116924
  11. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med 145(4):284-93 (2006) PMID 16908919
  12. Research misconduct, retraction, and cleansing the medical literature: lessons from the Poehlman case. Ann Intern Med 144(8):609-13 (2006) PMID 16522625
  13. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Ann Intern Med 143(2):146-8 (2005) PMID 16027458
  14. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141(10):781-8 (2004) PMID 15545678
  15. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 141(6):477-8 (2004) PMID 15355883
  16. Peer review: integral to Science and indispensable to Annals. Ann Intern Med 139(12):1038-40 (2003) PMID 14678925
  17. The cost of institutional review board procedures in multicenter observational research. Ann Intern Med 139(1):77 (2003) PMID 12834327
  18. Reflections on medical journals: has progress made them better? Ann Intern Med 137(1):46-8 (2002) PMID 12093244
  19. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137(1):10-6 (2002) PMID 12093240
  20. Paying research subjects: an analysis of current policies. Ann Intern Med 136(5):368-73 (2002) PMID 11874309
  21. Core safeguards for clinical research with adults who are unable to consent. Ann Intern Med 135(7):514-23 (2001) PMID 11578155
  22. Sponsorship, authorship, and accountability. Ann Intern Med 135(6):463-6 (2001) PMID 11560460
  23. The Cochrane Collaboration. Ann Intern Med 135(4):309-12 (2001) PMID 11511165
  24. Adjustments for center in multicenter studies: an overview. Ann Intern Med 135(2):112-23 (2001) PMID 11453711
  25. Who is a peer? Ann Intern Med 134(4):346-7 (2001) PMID 11182858
  26. Reporting standards and the transparency of trials. Ann Intern Med 134(2):169-72 (2001) PMID 11177328
  27. Institutional review boards: a crisis in confidence. Ann Intern Med 134(2):161-3 (2001) PMID 11177321
  28. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med 134(2):152-7 (2001) PMID 11177319
  29. Authors, editors, and readers in the brave new (electronic) world. Ann Intern Med 134(1):78 (2001) PMID 11187424
  30. Young physician-scientists: internal Medicine's challenge. Ann Intern Med 133(10):831-2 (2000) PMID 11085847
  31. News from the International Committee of Medical Journal Editors. Ann Intern Med 133(3):229-31 (2000) PMID 10906840
  32. The medical review article revisited: has the science improved? Ann Intern Med 131(12):947-51 (1999) PMID 10610646
  33. Fire ant attacks on residents in health care facilities: a report of two cases. Ann Intern Med 131(6):424-9 (1999) PMID 10498558
  34. Medical Writings revisited. Ann Intern Med 131(5):389-90 (1999) PMID 10475893
  35. Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med 130(12):1005-13 (1999) PMID 10383350
  36. Care at the end of life: guiding practice where there are no easy answers. Ann Intern Med 130(9):772-4 (1999) PMID 10357697
  37. Disclosure of researcher contributions: a study of original research articles in The Lancet. Ann Intern Med 130(8):661-70 (1999) PMID 10215563
  38. Masking, blinding, and peer review. Ann Intern Med 129(2):165 (1998) PMID 9669986
  39. Ethics manual. Fourth edition. American College of Physicians. Ann Intern Med 128(7):576-94 (1998) PMID 9518406
  40. Masking, blinding, and peer review: the blind leading the blinded. Ann Intern Med 128(1):66-8 (1998) PMID 9424984
  41. Integrating heterogeneous pieces of evidence in systematic reviews. Ann Intern Med 127(11):989-95 (1997) PMID 9412305
  42. Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-6 (1997) PMID 9382404
  43. Selecting and appraising studies for a systematic review. Ann Intern Med 127(7):531-7 (1997) PMID 9313021
  44. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 127(5):380-7 (1997) PMID 9273830
  45. The relation between systematic reviews and practice guidelines. Ann Intern Med 127(3):210-6 (1997) PMID 9245227
  46. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med 127(1):37-42 (1997) PMID 9214251
  47. Using systematic reviews in clinical education. Ann Intern Med 126(11):886-91 (1997) PMID 9163290
  48. Locating and appraising systematic reviews. Ann Intern Med 126(7):532-8 (1997) PMID 9092319
  49. Systematic reviews: critical links in the great chain of evidence. Ann Intern Med 126(5):389-91 (1997) PMID 9054284
  50. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126(5):376-80 (1997) PMID 9054282
  51. Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment. Ann Intern Med 125(12):990-1000 (1996) PMID 8967711
  52. Megatrials for clinical decision making. Ann Intern Med 125(7):621; author reply 621-2 (1996) PMID 8815765
  53. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125(7):605-13 (1996) PMID 8815760
  54. Does editorial peer review work? Ann Intern Med 121(1):60-1 (1994) PMID 8198351
  55. Medical treatment for stroke prevention. Ann Intern Med 121(1):41-53 (1994) PMID 7880225
  56. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120(8):667-76 (1994) PMID 8135452
  57. New international ethical guidelines for research involving human subjects. Ann Intern Med 119(4):339-41 (1993) PMID 8328746
  58. Conflict of interest. International Committee of Medical Journal Editors. Ann Intern Med 118(8):646-7 (1993) PMID 8452334
  59. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 301(13):1367-72 (2009) PMID 19336712
  60. Internet-based learning in the health professions: a meta-analysis. JAMA 300(10):1181-96 (2008) PMID 18780847
  61. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA 299(15):1813-7 (2008) PMID 18413875
  62. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 299(15):1800-12 (2008) PMID 18413874
  63. Issues in the registration of clinical trials. JAMA 297(19):2112-20 (2007) PMID 17507347
  64. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297(11):1233-40 (2007) PMID 17374817
  65. How conducting a clinical trial affects physicians' guideline adherence and drug preferences. JAMA 295(23):2759-64 (2006) PMID 16788131
  66. Second-order peer review of the medical literature for clinical practitioners. JAMA 295(15):1801-8 (2006) PMID 16622142
  67. Effect of blinded peer review on abstract acceptance. JAMA 295(14):1675-80 (2006) PMID 16609089
  68. Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA 295(11):1281-7 (2006) PMID 16537738
  69. Medical treatment of peripheral arterial disease. JAMA 295(5):547-53 (2006) PMID 16449620
  70. Differences in review quality and recommendations for publication between peer reviewers suggested by authors or by editors. JAMA 295(3):314-7 (2006) PMID 16418467
  71. Randomized trials stopped early for benefit: a systematic review. JAMA 294(17):2203-9 (2005) PMID 16264162
  72. Relative citation impact of various study designs in the health sciences. JAMA 293(19):2362-6 (2005) PMID 15900006
  73. Digital information archiving policies in high-impact medical and scientific periodicals. JAMA 292(22):2724-6 (2004) PMID 15585731
  74. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 292(17):2130-40 (2004) PMID 15523074
  75. Authorship criteria and disclosure of contributions: comparison of 3 general medical journals with different author contribution forms. JAMA 292(1):86-8 (2004) PMID 15238595
  76. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291(20):2457-65 (2004) PMID 15161896
  77. Different patterns of duplicate publication: an analysis of articles used in systematic reviews. JAMA 291(8):974-80 (2004) PMID 14982913
  78. NIH peer review of grant applications for clinical research. JAMA 291(7):836-43 (2004) PMID 14970062
  79. Comparison between impact factors and citations in evidence-based practice guidelines. JAMA 290(6):755-6 (2003) PMID 12915427
  80. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290(4):495-501 (2003) PMID 12876092
  81. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289(4):454-65 (2003) PMID 12533125
  82. Analysis of cases of harm associated with use of health information on the internet. JAMA 287(21):2869-71 (2002) PMID 12038937
  83. Qualitative and quantitative measures of indexed health sciences electronic journals. JAMA 287(21):2865-6 (2002) PMID 12038935
  84. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA 287(21):2853-6 (2002) PMID 12038932
  85. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA 287(21):2847-50 (2002) PMID 12038930
  86. Postpublication criticism and the shaping of clinical knowledge. JAMA 287(21):2843-7 (2002) PMID 12038929
  87. US legal principles and confidentiality of the peer review process. JAMA 287(21):2839-41 (2002) PMID 12038928
  88. Publication bias in editorial decision making. JAMA 287(21):2825-8 (2002) PMID 12038924
  89. Effects of technical editing in biomedical journals: a systematic review. JAMA 287(21):2821-4 (2002) PMID 12038923
  90. Association of journal quality indicators with methodological quality of clinical research articles. JAMA 287(21):2805-8 (2002) PMID 12038918
  91. Discussion sections in reports of controlled trials published in general medical journals. JAMA 287(21):2799-801 (2002) PMID 12038916
  92. Identifying manuscript reviewers: randomized comparison of asking first or just sending. JAMA 287(21):2795-6 (2002) PMID 12038915
  93. Prodding tardy reviewers: a randomized comparison of telephone, fax, and e-mail. JAMA 287(21):2794-5 (2002) PMID 12038914
  94. Author perception of peer review: impact of review quality and acceptance on satisfaction. JAMA 287(21):2790-3 (2002) PMID 12038913
  95. Measuring the quality of editorial peer review. JAMA 287(21):2786-90 (2002) PMID 12038912
  96. Effects of editorial peer review: a systematic review. JAMA 287(21):2784-6 (2002) PMID 12038911
  97. The hidden research paper. JAMA 287(21):2775-8 (2002) PMID 12038909
  98. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA 287(21):2769-71 (2002) PMID 12038907
  99. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287(5):612-7 (2002) PMID 11829700
  100. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281(20):1900-5 (1999) PMID 10349893
  101. Freedom and responsibility in medical publication: setting the balance right. JAMA 280(3):300-2 (1998) PMID 9676691
  102. Ethical issues in studying submissions to a medical journal. JAMA 280(3):290-1 (1998) PMID 9676686
  103. The reported training and experience of editors in chief of specialist clinical medical journals. JAMA 280(3):286-7 (1998) PMID 9676684
  104. Reviewing the reviews: the example of chronic fatigue syndrome. JAMA 280(3):264-6 (1998) PMID 9676676
  105. Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German. JAMA 280(3):247-9 (1998) PMID 9676671
  106. US and non-US submissions: an analysis of reviewer bias. JAMA 280(3):246-7 (1998) PMID 9676670
  107. Masking author identity in peer review: what factors influence masking success? PEER Investigators. JAMA 280(3):243-5 (1998) PMID 9676669
  108. Does masking author identity improve peer review quality? A randomized controlled trial. PEER Investigators. JAMA 280(3):240-2 (1998) PMID 9676668
  109. Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA 280(3):234-7 (1998) PMID 9676666
  110. What makes a good reviewer and a good review for a general medical journal? JAMA 280(3):231-3 (1998) PMID 9676665
  111. Reliability of editors' subjective quality ratings of peer reviews of manuscripts. JAMA 280(3):229-31 (1998) PMID 9676664
  112. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342(25):1887-92 (2000) PMID 10861325
  113. Ethical complexities of conducting research in developing countries. N Engl J Med 337(14):1003-5 (1997) PMID 9309109
  114. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337(8):536-42 (1997) PMID 9262498
  115. Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med 336(24):1722-9 (1997) PMID 9180090
  116. Sponsorship, authorship, and accountability. West J Med 175(4):259 (2001) PMID 11577056
  117. Which guidelines can we trust?: Assessing strength of evidence behind recommendations for clinical practice. West J Med 174(4):262-5 (2001) PMID 11290685
  118. The peer review process. West J Med 151(5):561 (1989) PMID 2603425
  119. Occurrence and persistence of bacterial and viral faecal indicators in wastewater biofilms. Water Sci Technol 55(8-9):377-85 (2007) PMID 17547008

2 Andere Lexika[Bearbeiten]